packageBrodalumab

brodalumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Brodalumab is a monoclonal antibody used to treat psoriasis. It is authorised in the European Union for psoriasis and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q4972934 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:brodalumab
ATC codes:L04AC12
DrugBank:DB11776
Wikidata:Q4972934

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown